Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Nail Diseases and Treatments, and Antibiotics Pharmacokinetics and Efficacy.
Can fluconazole be used to treat non-resistant Candida (Candidozyma) auris infections? Preclinical PK/PD data from a Galleria mellonella infection model.
Beyond <i>Candida</i>: Epidemiological Insights into Rare Yeast Fungaemia in Greece from a 15-Year Hospital-Based Study and Literature Review.
Evaluation of Sensititre YeastOne for antifungal susceptibility testing of <i>Candida (Candidozyma) auris</i>: misclassification of <i>FKS1</i> mutants and overestimation of caspofungin resistance in a global collection of isolates.
Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection model.
Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of
<i>Aspergillus fumigatus</i>
to echinocandins with the EUCAST E.Def 9.4
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.
Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories.
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
In Vitro Interactions Between Bacteriophages and Antibacterial Agents of Various Classes Against Multidrug-Resistant Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i> Clinical Isolates.
Detection of Phage's Lytic Activity Against Carbapenemase-Producing Klebsiella pneumoniae Isolates Using a High-Throughput Microbroth Growth Inhibition Assay.
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2-Year Single-Centre Study.
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver.
A multicentre study for determination of epidemiological cut-off values for Candida auris with EUCAST broth microdilution reference methodology.
Antifungal susceptibility testing and determination of local epidemiological cut-off values for <i>Candida</i> species isolated from women with vulvovaginal candidiasis.
Performance Evaluation of Five Real-Time PCR Assays for the Detection of Candida auris DNA.
EUCAST olorofim MICs for 3,550 Danish mold and dermatophyte isolates from 2020 to 2023.
The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniae.
Rare Mould Fungaemia at a Tertiary Academic Hospital in Athens, Greece: A 15-Year Survey and Literature Review.
Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations.
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model.
<i>Candidozyma auris</i> Outbreak and Its Effective Control in a General Hospital.
Evaluation of the MIC test strips for antifungal susceptibility testing of <i>Candidozyma auris</i> (<i>Candida auris</i>) using a representative international collection of isolates.
Evaluation of the Vitek 2 system for antifungal susceptibility testing of <i>Candida auris</i> using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance.
Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023
Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.
A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens.
Defining Optimal Doses of Liposomal Amphotericin B Against Candida auris: Data From an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?
Neonatal Fungemia by Non-Candida Rare Opportunistic Yeasts: A Systematic Review of Literature.